|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 314 out of 314 for Gcgr

<< First    < Previous  |  Next >    Last >>
0.021s
Type Details Score
GXD Expression  
Probe: MGI:5550066
Assay Type: Immunohistochemistry
Annotation Date: 2014-03-10
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1750327
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:5550086
Age: postnatal day 1
Note: The number of cells co-expressing Nestin and Glucagon decreased abruptly and were not observed in the Gcgr mutant P1 islets.
Specimen Label: not shown
Detected: true
Specimen Num: 12
Allele
Name: glucagon receptor; endonuclease-mediated mutation 2, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Not Specified
Allele
Name: glucagon receptor; endonuclease-mediated mutation 4, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Conditional ready, No functional change
GXD Expression  
Probe: MGI:5550066
Assay Type: Immunohistochemistry
Annotation Date: 2014-03-10
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3532827
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:5550086
Age: postnatal day 1
Note: A large number of immunopositive cells were observed in the exocrine compartment of the Gcgr mutant. Co-expression with Amylase was noted.
Specimen Label: not shown
Detected: true
Specimen Num: 15
Genotype
Symbol: Gcgr/Gcgr
Background: C57BL/6J-Gcgr
Zygosity: hm
Has Mutant Allele: true
DO Term
Publication
First Author: Zhu L
Year: 2017
Journal: J Clin Invest
Title: Hepatic β-arrestin 2 is essential for maintaining euglycemia.
Volume: 127
Issue: 8
Pages: 2941-2945
Publication
First Author: Wang MY
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway.
Volume: 112
Issue: 8
Pages: 2503-8
Publication  
First Author: Nason SR
Year: 2021
Journal: JCI Insight
Title: Glucagon receptor signaling regulates weight loss via central KLB receptor complexes.
Volume: 6
Issue: 4
Publication
First Author: Spolitu S
Year: 2019
Journal: Circ Res
Title: Hepatic Glucagon Signaling Regulates PCSK9 and Low-Density Lipoprotein Cholesterol.
Volume: 124
Issue: 1
Pages: 38-51
Publication
First Author: Jun LS
Year: 2015
Journal: Diabetes
Title: Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production.
Volume: 64
Issue: 3
Pages: 819-27
Publication
First Author: Kjeldsen SAS
Year: 2021
Journal: J Endocr Soc
Title: Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism.
Volume: 5
Issue: 9
Pages: bvab084
Publication  
First Author: Lang S
Year: 2020
Journal: BMJ Open Diabetes Res Care
Title: Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes.
Volume: 8
Issue: 1
Publication
First Author: Han J
Year: 2015
Journal: PLoS One
Title: The Identification of Novel Protein-Protein Interactions in Liver that Affect Glucagon Receptor Activity.
Volume: 10
Issue: 6
Pages: e0129226